The Company is dedicated to the innovative development of non-invasive wearable neuromodulation devices specifically designed for the treatment of neurodegenerative diseases. It has successfully created a comprehensive non-invasive wearable technology platform, which effectively alleviates both the motor and non-motor symptoms associated with Parkinson's Disease. Furthermore, the Company has established a robust deep intellectual property pipeline, currently holding multiple granted patents and an additional three pending patents in the United States. In addition, it has completed four significant clinical trials, showcasing its commitment to advancing research and patient care in this important field.